4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor α agonists

Add time:08/23/2019    Source:sciencedirect.com

Aromatic retinoids having a meta-substituted aromatic ring bridge, such as 4-[3-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and its 3,5-diaryl-substituted 4,5-dihydroisoxazole analogue, function as retinoid receptor panagonists by activating both retinoic acid and retinoid X receptors to induce gene transcription, and thereby provide novel scaffolds for retinoid drug development. Both classes of these ligand-inducible transcription factors are involved in mediating the inhibitory effects of retinoids on cancer cell growth.

We also recommend Trading Suppliers and Manufacturers of 6-[(1,2,3,4-Tetrahydro-1,1,4,4-tetramethylnaphthalene)-6-ylcarbonyl]-2-naphthalenecarboxylic acid (cas 110952-26-6). Pls Click Website Link as below: cas 110952-26-6 suppliers

Prev:Application of the Heck reaction in the synthesis of truncated naphthoic acid retinoids
Next:Enantioselective microbial reduction of 2-oxo-2-(1′,2′,3′,4′-tetrahydro-1′,1′,4′,4′-tetramethyl-6′-naphthalenyl)acetic acid and its ethyl ester)